Menu Search
Equities

Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG

EFF:BER

Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG

Actions
  • Price (EUR)0.50
  • Today's Change0.078 / 18.48%
  • Shares traded0.00
  • 1 Year change-38.65%
  • Beta--
Data delayed at least 15 minutes, as of Nov 06 2024 07:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Deutsche Effecten und Wechsel Beteiligungsgesellschaft AG is a Germany-based, bank-independent private equity company that operates internationally. It concentrates on medium capitalized technology companies and supports them by equity capital, consults in corporate development and its sector network. The Company focuses its investments on companies operating primarily in the area of photonics and sensor systems. As of December 2011, the Company's portfolio consisted of Nanotron Technologies Ltd (engaged in wireless sensor networks, among others), IG Asset, Inc (engaged in the functional genome analysis), NOXXON Pharma AG (engaged in the development of pharmaceuticals on the basis of Spiegelmer technology)l, and iTAC Software (engaged in collaborative production management system for the discrete manufacturing industry). In June 2014, the Company acquired MueTec GmbH.

  • Revenue in EUR (TTM)949.00k
  • Net income in EUR-1.01m
  • Incorporated2000
  • Employees1.00
  • Location
    Deutsche Effecten und Wechsel Beteiligungsgesellschaft AGFraunhoferstrasse 1JENA 07743GermanyDEU
  • Phone+49 36 413100030
  • Fax+49 36 413100040
  • Websitehttps://dewb.de/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.